Ernexa Therapeutics Inc. Deferred Compensation Liability, Current
Ernexa Therapeutics Inc. (ERNA) had Deferred Compensation Liability, Current of $815.00 thousand as of 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationLiabilityCurrent · last filed 2014-05-15
- 2014-03-31: Deferred Compensation Liability, Current $815.00K.
- 2013-12-31: Deferred Compensation Liability, Current $647.00K.
- 2013-09-30: Deferred Compensation Liability, Current $813.00K.
- 2013-06-30: Deferred Compensation Liability, Current $616.00K.
| Period end | Deferred Compensation Liability, Current |
|---|---|
| 2014-03-31 | $815.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $647.00K 10-Q · filed 2014-05-15 |
| 2013-09-30 | $813.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $616.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $832.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $598.00K 10-Q · filed 2013-11-14 |
| 2012-09-30 | $865.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $922.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $891.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $757.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $990.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $729.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $628.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |